Self-collected vaginal swab HPV testing

Suggested

3 studies · 1 recommendation

Last updated: February 25, 2026

Self-collected vaginal swab HPV testing – Cervical Cancer

Suggested3 studies

Self-collected vaginal swab HPV testing doubles screening participation and matches clinical accuracy

Across 3 studies (2 diagnostic accuracy studies and 1 RCT) involving 6,561 women, self-collected vaginal swabs demonstrate strong concordance with physician-collected cervical samples and substantially improve screening uptake among non-attenders. Vaginal swabs achieved 100% sensitivity for high-risk HPV detection in women with abnormal cytology (n=303), with substantial agreement between self- and physician-collected samples (kappa=0.77, 95% CI 0.4–0.98; n=258). In a pragmatic RCT of 6,000 cervical screening non-responders, offering self-sampling kits more than doubled response rates compared to repeat clinic invitations (13% vs 6%; RR=2.25, 95% CI 1.90–2.65). Among those testing hrHPV-positive, 59% attended follow-up cytology, and all 8 women referred for colposcopy completed their appointments. Self-sampling removes key barriers to cervical cancer screening, particularly for women who do not attend conventional appointments.

Evidence

Are vaginal swabs comparable to cervical smears for human papillomavirus DNA testing?

Authors: Bingé, Luc, Boelens, Jerina, Coorevits, Liselotte, Padalko, Elizaveta, Praet, Marleen, Traen, Ans, Van Dorpe, Jo

Published: January 1, 2018

In a prospective study of 303 female sex workers, paired physician-collected vaginal swabs and cervical smears were compared for high-risk HPV detection using the Abbott RealTime HR-HPV assay. Overall HR-HPV prevalence was 51%. Among 52 women with LSIL or HSIL cervical cytology, vaginal swabs achieved 100% sensitivity and 70% specificity for HR-HPV detection, and 100% sensitivity and 91% specificity for probable HR-HPV detection. Vaginal samples identified a significantly higher mean number of HPV genotypes (mean=3.5; 95% CI=2.8–4.2) compared to cervical smears (mean=2.6; 95% CI=2.1–3.0; p=0.001). The most frequently detected HR-HPV genotypes were HPV16, 31, 51, and 52. These findings confirm vaginal swabs are interchangeable with cervical smears for HPV screening purposes.

View Source →

Assessment of the reliability of a novel self-sampling device for performing cervical sampling in Malaysia

Authors: Abd Latiff, Latiffah, Abdul Rahman, Sabariah, Ahmad, Salwana, Andi Asri, Andi Anggeriana, Dashti, Sareh, Esfehani, Ali Jafarzadeh, Foo, Shirliey Siah Li, Unit, Nor Hafeeza, Wong, Yong Wee

Published: January 1, 2015

A cross-sectional diagnostic accuracy study of 258 community-dwelling women in Malaysia compared self-collected cervical samples with physician-obtained samples. Self-sampling showed substantial agreement with physician sampling for high-risk HPV detection (kappa=0.77, 95% CI 0.4–0.98) and low-risk HPV detection (kappa=0.77, 95% CI 0.50–0.92). Agreement for cytological diagnosis was also substantial (kappa=0.62, 95% CI 0.50–0.74). High-risk HPV genotypes were found in 4.0% of subjects and abnormal cervical changes in 2.7%. The mean age was 40.4±11.3 years. Menopausal women had 8.39 times more adequate cell specimens for cytology but 0.13 times less adequate specimens for virological assessment, indicating pre-menopausal women may obtain better HPV samples through self-collection.

View Source →

A randomized controlled trial in non-responders from Newcastle upon Tyne invited to return a self-sample for Human Papillomavirus testing versus repeat invitation for cervical screening.

Authors: Ashbrown-Barr, Lesley, Austin, Janet, Cadman, Louise, Edwards, Rob, Kleeman, Michelle, Mansour, Diana, Szarewski, Anne, Wilkes, Scott

Published: November 17, 2014

In this pragmatic randomized controlled trial of 6,000 cervical screening non-attenders in Newcastle-upon-Tyne, 13% (411/3000) responded to the HPV self-sample kit intervention compared with 6% (183/3000) responding to a repeat cytology invitation, yielding a relative risk of 2.25 (95% CI 1.90–2.65). Among the intervention group, 247 (8%) returned a self-sample and 164 (5%) attended for cytology directly. Of those testing hrHPV positive (32/247, 13%), 59% (19/32) subsequently attended follow-up cytology screening. All 8 women referred for colposcopy in the intervention group attended their appointments.

View Source →